Download Citation
Article Source:
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy
Bennett JW,
Yadava A,
Tosh D,
Sattabongkot J,
Komisar J,
et al.
(2016)
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.
PLOS Neglected Tropical Diseases 10(2): e0004423.
https://doi.org/10.1371/journal.pntd.0004423